Objective: To investigate the association of genetic variants in sortilin-related receptor (SORL1), which has been proposed as an important genetic contributor to lateonset Alzheimer disease (LOAD).
M

ULTIPLE SUSCEPTIBILITY
genes have been implicated as possible risk factors for late-onset Alzheimer disease (LOAD), but only the apolipoprotein E (APOE; NCBI Entrez Gene NM_000041.2) ε4 allele is recognized worldwide as a major contributor to the disease. Recently, sortilin-related receptor (SORL1; NCBI Entrez Gene NM_003105.4) has been proposed as another important genetic candidate for LOAD.
1 SORL1 is involved in intracellular trafficking and recycling the amyloid ␤ (A␤) peptide into the endocytic pathway. 1 Patients with Alzheimer disease (AD) have lower SORL1 expression levels, whereas SORL1 knockout animal models present increased brain A␤ levels, suggesting that SORL1 has an inhibiting effect on the A␤ protein precursor amyloidogenic pathways. 2, 3 Several different association studies 4 (Table1) have linked genetic variants within the SORL1 gene (11q23-q24) with LOAD. Two clusters of different singlenucleotide polymorphisms (SNPs) and haplotypes located at the 3Ј and 5Ј ends of the SORL1 gene were associated with risk of developing familial and sporadic forms of AD in samples of different ethnic origins, suggesting a marked allelic heterogeneity at this locus. In particular, 8 studies 1,5-11 reported positive allelic and haplotypic associations between AD and SORL1 variants. In addition, one study 12 found that SORL1 variants contributed to the subclinical phenotypes (ie, preclinical cognitive dysfunction), whereas Kölsch et al 13 suggested that SORL1 SNPs may relate to altered cerebrospinal fluid A␤ levels in patients with AD.
Two recent studies 14, 15 did not confirm this finding, although the data from Shibata et al 14 have been recently reanalyzed 17 and 2 SNPs were significantly associated with the Japanese AD population. A large genome-wide association study 16 failed to detect an association between SORL1 and AD; however, it was likely confounded by allelic/nonallelic heteroge-neity owing to multiple ethnic origins of the data set. Intriguingly, this study suggested that another gene that is functionally and structurally related to SORL1 (SORCS1) may be associated with AD. A systematic meta-analysis 18 of family-based data (http://www.alzforum.org) failed to confirm the association of the SORL1 gene with AD risk, whereas a recent study 19 reporting an association of some genetic variants with cerebrovascular and neurodegenerative changes related to AD supports the idea that multiple areas in SORL1 are of functional importance.
To date, the exact identity of the pathogenic variants of SORL1 remains to be identified. To further investigate the proposed influence of the SORL1 gene on AD, we analyzed the distribution of 13 different SNPs and their correlating haplotypes, which have already been reported as being involved in LOAD, in a case-control study of an Italian population.
METHODS
The Italian sample included 708 subjects: 251 unrelated, sporadic patients with LOAD (157 women and 94 men; mean (SD) age at onset, 71.8 [5.2] 20, 21 None of the patients with AD had a documented family history of dementia. The ethics committee approved the study protocol, and informed, written consent was obtained from each patient or, when appropriate, from a caregiver. Healthy participants were recruited from the same region and underwent a rigorous diagnostic evaluation to exclude any possible neurological disorders.
Genomic DNA was extracted from blood samples, and genotyping of the SORL1 SNPs was carried out by polymerase chain reaction and high-resolution melting analysis 22 using the realtime cycler (Rotor-Gene 6000; Corbett Life Science, Mortlake, Australia).
APOE was genotyped with polymerase chain reaction and restriction fragment length polymorphism. For each SNP, the 2 test was used to evaluate the risk across the genotype categories of each polymorphism and SORL1 haplotype (Epi Info software, version 3.3.2; http://www.cdc.gov/EpiInfo/).
Statistical analysis was performed using SPSS statistical software, version 15 (SPSS Inc, Chicago, Illinois). The effects of APOE ε4 allele status and SORL1 genotype alone and in combination were assessed using a logistic regression analysis adjusted for age and sex. Age at onset between the genotype groups was compared using analysis of variance. PϽ.05 was considered statistically significant. Haplotype frequencies were calculated using PowerMarker software, version 3.25 (http://statgen.ncsu.edu/powermarker/). 23 The P values for the overall significance of association for all haplotypes were obtained using a permutation-based algorithm implemented with the software CLUMP, thereby negating the need for Bonferroni correction. 24 Power analysis was performed using COMPARE2 software (http://www.brixtonhealth.com /pepi4windows.html).
RESULTS
We genotyped a total of 13 SNPs (4-10, 17, 19, 22-25) in the SORL1 gene, numbered according to the previous publication by Rogaeva et al. 1 According to previous reports and to the HapMap project, the analyzed SNPs are adequately representative of the block structure of the 2 clusters (5Ј and 3Ј) in the SORL1 gene that have been associated with AD.
Genotype and allele frequencies for the SORL1 polymorphism are shown in Table 2 . In both the AD and control populations, none of the SNPs deviated from the Hardy-Weinberg equilibrium.
The individual SNP analysis revealed that SORL1 SNP 4 (rs661057) was significantly associated with LOAD compared with controls for both the T allele (68.5% vs 59.6%; P=.002; odds ratio [ Table 3) . Of interest, the LOAD association for this SNP was confined to APOE Table 4) . Among APOE ε4 carriers, the differences were not statistically significant. In addition, no effect of SNP 4 on age at onset was detected in patients with LOAD.
Among APOE ε4 noncarriers, women had a significantly higher frequency of the T/T genotype (PϽ.001; OR, 2.41 [95% CI, 1.38-4.19]) and T allele (PϽ.001; 2.0 [1.31-3.06]), which confirms a sex effect for this SNP ( Table 5) .
We also found a marginally significant association with LOAD for SORL1 SNP 7 (rs12364988) with the G allele Among men, no differences were found in the overall distribution of SNPs 4, 7, and 10 for patients with LOAD vs controls. In addition, differences in allele and genotype frequencies between patients and controls did not reach statistical significance for the other SNPs in the SORL1 gene (Table 2) .
Haplotype analysis, performed using a 3-marker contiguous sliding window, demonstrated several haplotypic associations clustered at the 5Ј end of SORL1 (Table 6 ). Different at-risk haplotypes covering SNPs 4 through 9 were found, whereas the CAA haplotype (SNPs 4-6) and the ACG haplotype (SNPs 7-9) had a protective effect. The CGC haplotype at SNPs 8, 9, and 10 was significantly associated with LOAD (P=.03; OR,1.29), as previously reported. Intriguingly, we were not able to replicate, in our case-control sample, the reported association of haplotypes at the 3Ј region of SORL1, reflecting the lack of association of the single SNP analysis in this region.
COMMENT
Based on previous genetic and functional evidence suggesting an important biological role for the SORL1 gene in AD pathogenesis, we analyzed the possible association of some genetic variants in an Italian case-control sample.
Our findings of an association with 3 variants (SNPs 4, 7, and 10) within the 5Ј region confirm the results of prior studies supporting a positive contribution to AD by this region. In addition, we found an association of both the TT genotype (P = .002; OR, 1.7) and T allele (P=.002; OR,1.47) at SNP 4 (rs661057) with the likelihood of developing AD. This SNP has previously been detected with a similar OR and P value in combined Mayo Clinic and white case-control data sets from the first report on SORL1, 1 and SNP 10 was associated with AD in earlier reports. 1, 9 Although the association of SNP 4 with LOAD is stronger, the association of SNPs 7 and 10 cannot survive a multiple-testing correction for the number of analyzed markers. We should comment that this correction could produce inappropriate results 6 ; we attempted to replicate previous investigations, and the associated polymorphisms were in the same region and in a high rate of linkage disequilibrium with SNPs involved in previous studies. 4 Consequently, they could not be considered independent tests.
A similar haplotypic association subsists in the 5Ј region. No other marker or haplotype reached significance in our sample, including the SNPs in the 3Ј cluster, which are reported to influence AD in white populations in many, 1, [5] [6] [7] [8] [9] but not all, of the published studies, suggesting allelic heterogeneity in this SORL1 region.
Moreover, we had a power range of 98.3% to 99.5% to detect an OR of 2.0 for the examined SNPs (power range, 69%-80% for a 1.5-fold increased risk), assuming an ␣ level of .05. Thus, this study should be sufficiently powerful to verify other positive associations, although we cannot exclude that the other analyzed SNPs (including the 3Ј region) could confer only a very low effect on risk, or small effects at the observed minor allele frequencies, that was undetectable within this sample. Comparing controls with a group of 99 patients with early-onset AD, allele and genotype distributions for all of the genetic variants did not differ (data not shown), confirming that the SORL1 pathogenic effect affects only LOAD.
Although most studies 1,5-13,17 reported a genetic contribution of SORL1 to the disease, not all studies have found a univocal association with AD. To date, no common coding polymorphisms in SORL1 exons have been correlated with functional effects; therefore, we could hypothesize that SNP 4, localized in the noncoding region of this gene, might have a regulatory role. It is also possible that this polymorphism may be in linkage disequilibrium with a near SNP that is contributing to the risk of AD.
In addition, our data confirm the association between the APOE ε4 allele and LOAD (PϽ.001; data not shown). We performed stratification of SORL1 SNPs by APOE genotype and observed an increased risk of AD in APOE ε4 noncarriers, suggesting that the risks associated with SORL1 and AD were independent of APOE ε4 status.
Among APOE ε4 carriers, SNP 4 was previously weakly associated with AD risk 15 ; SNP 8 was more prevalent among APOE ε4 noncarriers, 17 but no other interactions were reported between SORL1 variants and APOE. The association of SORL1 and AD independent of APOE ε4 allele status remains controversial and requires further investigation.
The pathogenic mechanism of SORL1 that leads to AD could be independent of APOE; therefore, in patients not carrying the APOE ε4 allele as a genetic risk factor, SORL1 variants could be important determinants for disease susceptibility.
In addition, we found an association between SORL1 variants and sex; our data suggest that SORL1 may affect LOAD through a female-specific mechanism. The overall risk for AD seems to be higher among women than men. 25 However, it is not clear whether this is because of the longer life expectancy among women at ages when AD is common or other confounding factors, such as education, occupation, and some lifestyle variables. 26 Nevertheless, the increased risk conferred by SORL1 variants among women, suggested by our data, requires further confirmation because it may simply reflect a smaller sample size for men. The possible effect of these SNPs in relation to sex and the APOE-stratified analysis should be verified in other samples, including a larger sample of men.
Our results replicate in an Italian population the findings that SORL1 genetic variants may modify the LOAD risk, although with a marked allelic heterogeneity. However, taken together, the results of genetic and expression studies of SORL1 show that the association with AD should not be considered spurious; SORL1 could be one of the most attractive candidate genes for AD pathogenesis, but its effect might not be as strong as initially observed.
Further efforts should be carried out to detect the real pathogenic variants associated with AD and to determine whether they contribute to the AD risk in a sexinfluenced way. Identification of the functional causative variants influencing SORL1 expression and/or levels may help clarify their role in the pathogenesis of LOAD and may point to possible future therapeutic strategies. 
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